SAN JOSE — Another day at the rink, another remarkable milestone in Sharks territory.After witnessing the franchise’s 1,000th win (Jan. 10), Brent Burns’ 1,000th game (Dec. 27), Joe Thornton’s 1,500th game (Nov. 8) and the alternate captain’s 400th goal (Nov. 13), Sharks fans will be treated to another rare feat at SAP Center Tuesday. Thornton will suit up for his 1,000th game with the Sharks, joining Patrick Marleau on the list of players who’ve made it that far in a teal jersey when his team …
The Congress in Maharashtra on Sunday said it didn’t want President’s Rule in the State which is in the midst of a political crisis in view of the BJP’s announcement that it would not form government. Senior Congress leader Ashok Chavan said newly-elected MLAs of the party will seek advice from the party high-command over its future political stand in the State. “We are in Jaipur. We will discuss the issue here and will seek advice for the future political stand. The party doesn’t want president’s rule in the state,” he told reporters. Mr. Chavan said he was in favour of forming a stable government in Maharashtra.
Richard Klein switched doctors last year. The new doctor put him on a new blood pressure drug. But it didn’t help. The failure was entirely predictable.Klein, an associate professor at Florida International University in Miami, realized later that he had tried the same medicine unsuccessfully a few years before, but he hadn’t remembered that fact during the appointment.It was an understandable mistake for Klein and his doctor.Klein’s prescription history was hidden somewhere in the hundreds of pages of medical records his new doctor had to go through.”If I had been able to go into an app sitting in his office and look through my prescription history, I would have known that, yeah, we tried that a couple years back and it didn’t work well,” he says.A feature like that will soon be available for some patients with iPhones.In the upcoming release of Apple’s iOS operating system for iPhones this spring, the Health app will include health records, so patients can take information about their immunizations, medications, lab results and more with them.The feature will first be available to patients of medical providers who partnered with Apple, including Johns Hopkins Medicine; OhioHealth; Ochsner Health System in Jefferson Parish, La.; and Cedars-Sinai in Los Angeles. It won’t cost those patients anything to use this feature, assuming they’re already iPhone users.Apple’s announcement says more medical facilities will offer this feature in the coming months.Some doctors hail it as a big shift away from patients having to handle a big pile of paper records every time they see a new doctor. But Google offered a similar service before and it failed. The search giant shut it down in 2012.Can Apple succeed where Google didn’t?Dr. Jonathan Slotkin says yes; he is a medical director handling digital patient engagement at Geisinger Health System in Pennsylvania, one of Apple’s partners. Unlike even a few years ago, a lot more people now use smartphones and the phones are more secure. There’s now also a technical standard for transferring electronic medical records.”Even if I get care at three different places and maybe they use three different electronic systems, now in one place that I possess in an encrypted way, I have all of that information at my fingertips,” he says.He adds this will make transferring information easier for patients who have to move, or go to a specialist.The health records feature could also change doctors’ habits in some ways, says Dr. Isaac Kohane, chair of the department of biomedical informatics at Harvard Medical School and a professor of pediatrics.”For some reason, and I say this as a physician, most physicians, if they don’t actually know how a test was done, somehow imagine it was done wrongly, and therefore repeat a test, not only at a cost but at some pain to the patient,” Kohane says. “If you have a reliable authoritative description of the test and its results, that uncertainty goes away and that excuse to repeat tests goes away as well.”Kohane called Apple’s new feature a “tectonic shift” in a commentary for member station WBUR’s CommonHealth.But Apple will have to address one big problem that Google had with Google Health, a similar health records service: It was popular with only a niche audience — tech-savvy patients and their caregivers, and fitness enthusiasts. The product didn’t attract a wide base of users.This time will be different, says Dr. Ida Sim, a co-director of biomedical informatics at the University of California, San Francisco Clinical and Translational Sciences Institute. Why? Because unlike with Google Health, patients no longer have to do the heavy lifting of entering or scanning their own data. Also, the 21st Century Cures Act of 2016 pushed federal agencies and providers to use electronic health records, and now there is a data standard for personal health records, which wasn’t the case in 2011.However, she writes in an email that wider adoption will still be an issue.”We’ll probably see huge numbers of people getting their initial Health Records populated. The issue is, then what?… The value will come from third party apps that use Health Records to provide meaningful value to patients, and until this value is demonstrated, I think Health Records uptake will be large but retention and continued engagement of patients will be challenging.”Alan Yu reports for The Pulse, WHYY’s health and science show. Copyright 2018 WHYY. To see more, visit WHYY.
The explosion of deaths related to opioid misuse has underscored a pressing need for better ways of treating pain, especially chronic pain.Duquesne University pharmacology associate professor Jelena Janjic thinks she’s on to one. It involves using a patient’s own immune system to deliver non-opioid pain medication to places in the body where there’s pain.Janjic’s idea, which draws from the field of cancer research, is to insert tiny amounts of over-the-counter pain medications into minute carriers called nanoparticles, and then inject these into pain patients. The medicines would then travel through the body to places where there is inflammation, and relieve the pain.Janjic has a special reason for wanting to develop new medicines for chronic pain: She suffers from it herself.”As a patient, I want an answer,” she says. “I want to figure out this.”There’s no question that the need for better, non-addictive medications is real and urgent. Researchers have come up with some ideas, but so far none has made it to market. Finding new treatments is difficult for any disease and it’s proving especially difficult for chronic pain because the underlying causes are poorly understood.Attempting to modulate inflammation as way to treat pain “is an active area of research,” says Michael L. Oshinsky, Program Director, Pain and Migraine, at the National Institute of Neurological Disorders and Stroke.Oshinsky says Janjic’s idea of targeting the immune system with nanoparticles carrying pain relievers makes sense, although he cautions that the relationship between inflammation and pain is not well understood.Janjic’s path to this research began in 2010. She has a doctorate in medicinal chemistry, and she had recently moved to Duquesne University where she had set up a lab focused on using nanomedicine techniques to treat cancer.What seemed like out of nowhere, of the blue, she started to suffer bouts of severe pain.”The one that hit me real hard was the whole body, from head to toe,” she says. “I’ve had on and off chronic pain since I was a teenager, but this was different.”In August that year, just before her students arrived back to school, she ended up in the emergency room with pain that was almost intolerable.The doctors’ diagnosis was discouraging. They told her she had a chronic pain syndrome. They said there wasn’t much they could do about it, and they said it was for life.The medicines they gave her helped with the pain somewhat, but left her feeling like she was living in a fog. She was having trouble remembering things, trouble taking notes.”Things were weird. So I decided I am going to do research on myself,” Janjic says.To control her own pain, she turned to mindfulness meditation and other non-medical interventions, including composing music and playing the piano. It’s not as if the pain magically went away, she says, but she was able to carry on with her life. Some days were worse than others.But she also wanted to find a medical solution.She made one important treatment decision early on: She didn’t want to take opioids for her pain.”At the time I could have got them very easily,” Janjic says. “I said, ‘What are you going to give me when I’m 67, or 87, if I take them now?’ I knew they don’t work long-term very well. So almost the refusal of opioids precipitated everything else that happened.”Looking for alternatives to opioids, she dove into the scientific literature, to learn all she could about chronic pain.Chronic pain syndromes are not well understood. With acute pain, it’s usually possible to identify the cause—an injury of some sort, or inflammation caused by an infection. Chronic pain may be linked to an initial mishap, but may persist long after the initial cause of the pain has disappeared. Sometimes there’s no good explanation of the pain at all, a frustrating circumstance for both doctor and patients.In addition to her research, Janjic started paying close attention to her own condition.”I started to understand that my body was actually inflamed,” she says.Inflammation occurs when our bodies’ immune system tries to deal with some damage, maybe from an invading virus or bacteria, and sends a barrage of immune cells to the affected area. On the one hand this is a good thing, since the cells fight the infection. But on the other, it can stimulate nerve cells in a particular part of the body, causing pain.Janjic also noticed something important about her pain: it varied both in intensity and in location. Sometimes it was in her knees, sometimes in her shoulders.She says none of the medicines available today responded to pain’s “diversity within the body.””I [started] to understand the fluctuation,” she says.She realized that the fluctuation meant more immune cells were going to the part of the body where the pain was. She figured if she could get pain medicine into immune cells, that medicine would ride with those cells to where it was needed.Before she got into pain research, Janjic was working on something called cancer nanomedicine. Cancer nanomedicines work by putting anti-cancer drugs into tiny containers called nanoparticles, and then injecting them into cancer patients, where they enter the patients’ immune cells.”So what did I already know how to do? Mess with the immune system with nanomedicines,” Janjic says. “And that’s how the idea of pain nanomedicine was born.”After many years of tinkering, she’s started to get positive results. In a recently published study, she showed that when researchers put a nonsteroidal, anti-inflammatory drug into a nanoparticle, and then injected that into a rat, it reduced the rat’s pain.Janjic says her approach doesn’t try to disable the immune cells.”You still want them to fight infection, you still want them to do what they’re supposed to do,” she says. “But we almost try to stop them from going into override and causing chronic pain.”Janjic, who is also the founder and co-director of the Chronic Pain Research Consortium at Duquesne University, is collaborating with several labs to try pairing different pain medications with different kinds of nano-particles to see what works best. So far progress is slow. And if one of the candidates shows real promise it will be years before anything can be tested in human patients and ultimately approved by the FDA.Janjic credits her own experience with pain for helping her gain a better understanding of pain and how to treat it. She thinks researchers would learn a lot from routinely talking to the people they’re trying to help.”My take home message is, ‘Ask the patient first,’ ” Janjic says. “Ask the kid who’s ten. Ask the grandpa with rheumatoid arthritis what that feels like. This is what I really want to see flourish. Maybe this already happening somewhere. If it is, I want to know. If you are inspiring your research this way, then I want to talk to you.” Copyright 2018 NPR. To see more, visit http://www.npr.org/.